temozolomide has been researched along with Craniopharyngioma in 3 studies
Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
Excerpt | Relevance | Reference |
---|---|---|
"Temozolomide is an alkylating chemotherapeutic agent used routinely in the management of high grade gliomas." | 1.37 | MGMT immunoexpression in adamantinomatous craniopharyngiomas. ( Altuntaş, Y; Aydın, Y; Karaman, O; Müslüman, AM; Ozderya, A; Ozkayalar, H; Oztürk, FY; Tanık, C; Zuhur, SS, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Raverot, G | 1 |
Ilie, MD | 1 |
Lasolle, H | 1 |
Amodru, V | 1 |
Trouillas, J | 1 |
Castinetti, F | 1 |
Brue, T | 1 |
Zairi, F | 1 |
Aboukais, R | 1 |
Maurage, CA | 1 |
Assaker, R | 1 |
Zuhur, SS | 1 |
Müslüman, AM | 1 |
Tanık, C | 1 |
Karaman, O | 1 |
Oztürk, FY | 1 |
Ozderya, A | 1 |
Ozkayalar, H | 1 |
Aydın, Y | 1 |
Altuntaş, Y | 1 |
1 review available for temozolomide and Craniopharyngioma
Article | Year |
---|---|
Aggressive pituitary tumours and pituitary carcinomas.
Topics: Craniopharyngioma; Humans; Immunotherapy; Pituitary Neoplasms; Temozolomide; Tumor Microenvironment | 2021 |
2 other studies available for temozolomide and Craniopharyngioma
Article | Year |
---|---|
Glioblastoma occurring after the surgical resection of a craniopharyngioma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Clinical Protocols; Cra | 2014 |
MGMT immunoexpression in adamantinomatous craniopharyngiomas.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor | 2011 |